Successful treatment of infection caused by Mycobacterium abscessus with phage therapy and antibiotics in combination treatment by researchers from the Université de Montpellier in France, together with researchers from the University of Pittsburgh.
The Federal Service for the Oversight of Consumer Protection and Welfare in Russia has recently taken on a hands-on approach toward the urgent need of addressing the problem against antibiotic-resistant bacteria with bacteriophages.
Proteon Pharmaceuticals receives funding from Nutreco, Aqua-Spark & PFR Life Science for commercializing bacteriophage-based products for livestock and aquaculture.
A new genus of bacteriophages; Colneyvirus created by scientists at the Institute of Food Research at Norwich Research Park, after the discovery of a phage against Clostridium difficile.
EU and FAO award Biochimpharm with grant for the production of a new product for veterinary use, PowerPhage.
TechnoPhage announces FDA Fast Track Designation granted to TP-102 for the treatment of patients with infected diabetic foot ulcers
TechnoPhage announces FDA Fast Track Designation granted to TP-102 for the treatment of patients with infected diabetic foot ulcers.
Phico Therapeutics raises £7 million investment to support SASPject novel engineered phage technology
Phico Therapeutics raises £7 million investment to support SASPject advancement, novel engineered phage technology for next-generation antibiotics to curb antimicrobial resistance (AMR).
The National Institute of Allergy and Infectious Diseases (NIAID), has awarded 12 institutes with grants towards phage therapy research.
Phico Therapeutics receives funding from CARB-X towards the development of engineered bacteriophage with SASP gene targeting Pseudomonas aeruginosa.